WHC is still in active development. Read this to understand our approach.
depiction of BGMZUEKZENQUJY-UHFFFAOYSA-N.svg
tripsit

doi

Verificar en tripsit

psychonaut

DOI

Verificar en psychonaut

isomerdesign

DOI

Verificar en isomerdesign

druglab

DOI

Verificar en druglab

drugmap

(R)-1-(4-iodo-2,5-di...

Verificar en drugmap

drugmap

(R)-1-(4-iodo-2,5-di...

Verificar en drugmap

drugmap

(R)-1-(4-iodo-2,5-di...

Verificar en drugmap

wiki

2,5-Dimethoxy-4-iodo...

Verificar en wiki

Data

InChI: InChI=1S/C11H16INO2/c1-7(13)4-8-5-11(15-3)9(12)6-10(8)14-2/h5-7H,4,13H2,1-3H3

Sinónimos: 1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane,BDBM28582,SDCCGSBI-0050451.P002,PDSP1_001383,1-(4-Iodo-2,5-dimethoxyphenyl)propan-2-amine,DOI,(+), CHEMBL134519,DB-008006,SCHEMBL293580, UNII-OOM10GW9UE, C11H16INO2, 4-Iodo-2,5-dimethoxy-alpha-methylbenzeneethanamine,NCGC00015302-04, CHEBI:64629,NCGC00015302-03,GTPL147,BENZENEETHANAMINE, 4-IODO-2,5-DIMETHOXY-.ALPHA.-METHYL-,DOI,(-),S(+)-DOI HCL, Lopac0_000478,Benzeneethanamine, 4-iodo-2,5-dimethoxy-alpha-methyl-,AKOS015965128,1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine,BGMZUEKZENQUJY-UHFFFAOYSA-, (R)-2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine,2,5-dimethoxy 4-iodoamphetamine, (2R)-1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine, Benzeneethanamine, 4-iodo-2,5-dimethoxy-alpha-methyl-,(+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane,NCGC00162163-01, (R)-2-(4-Iodo-2,5-dimethoxy-phenyl)-1-methyl-ethylamine, 64584-34-5,1-(4-Iodo-2,5-dimethoxyphenyl)-2-aminopropane,(+-)-DOI, Benzeneethanamine, 4-iodo-2,5-dimethoxy-alpha-methyl-, (alphaR)-,[125I]4-iodo-2,5-dimethoxyphenylisopropylamine, PDSP2_001372,(R)-1-(4-Iodo-2,5-dimethoxyphenyl)propan-2-amine,DTXSID7040520,4-Iodo-2,5-dimethoxyphenylisopropylamine,UNII-OOM10GW9UE,4-DOI, 82864-06-0,OOM10GW9UE,(+/-)-DOI,DOI, CHEMBL6616, SCHEMBL713061, 82830-53-3, 4-Iodo-2,5-dimethoxyamphetamine,82830-53-3,1-(4-Iodo-2,5-dimethoxyphenyl)-2-propanamine,Q209251,2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine,L000011,J246.190K, AJ-36945,Racemic DOI,(+/-)-1-(4-iodo-2,5-dimethoxyphenyl)-2-aminopropane, NCGC00162167-01, PDSP1_001388,A834816,MFCD05662244,4-Iodo-2,5-dimethoxy-alpha-methylbenzeneethanamine, 2,5-Dimethoxy-4-iodoamphetamine,CHEMBL6616, 4-DOI, 1-(4-Iodo-2,5-dimethoxyphenyl)-2-aminopropane, BDBM50133231,4-Iodo-2,5-dimethoxyamphetamine, ZINC2516053,[125I]2,5-dimethoxy-4-iodoamphetamine,2,5-Dimethoxy-4-iodophenylisopropylamine,Lopac0_000466,DOI-P,4-iodo-3-methoxy-N-(2-methoxy-1-methyl-ethyl)aniline, CCG-204569,F15177, 1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane, (R)-DOI, GTPL157,CCG-204558, 2,5-Dimethoxy-4-iodophenylisopropylamine,Benzeneethanamine,?4-iodo-2,5-dimethoxy-.alpha.-methyl-,CHEBI:64629,PDSP2_001367, (r)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane,3-(4-bromo[1,1-biphenyl]-4-yl)-1,2,3,4-tetrahydro-1-naphthol, 2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine, DOI-P,99665-04-0,2,5-Dimethoxy-4-iodoamphetamine, R-DOI,[125I]DOI,64584-34-5

Estimated data

Solubilidad: -2.365 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: No (prediction using frontiersin.org)

Addictivity Prediction: 87.9% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.